See more : JPMorgan Emerging Markets Investment Trust plc (JMG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Trulieve Cannabis Corp. (TRUL.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trulieve Cannabis Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Super Telecom Co.,Ltd (603322.SS) Income Statement Analysis – Financial Results
- Biofrontera AG (B8F.DE) Income Statement Analysis – Financial Results
- GLG Life Tech Corporation (GLG.TO) Income Statement Analysis – Financial Results
- Fyber N.V. (FBEN.DE) Income Statement Analysis – Financial Results
- OC Oerlikon Corporation AG (OERLF) Income Statement Analysis – Financial Results
Trulieve Cannabis Corp. (TRUL.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.trulieve.com
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13B | 1.24B | 938.39M | 521.53M | 252.82M | 102.82M | 19.78M | 161.15K |
| Cost of Revenue | 540.57M | 557.80M | 372.26M | 135.12M | -109.47M | -2.75M | 1.36M | 2.81M |
| Gross Profit | 588.63M | 682.00M | 566.13M | 386.42M | 362.28M | 105.56M | 18.42M | -2.65M |
| Gross Profit Ratio | 52.13% | 55.01% | 60.33% | 74.09% | 143.30% | 102.67% | 93.14% | -1,642.14% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 146.00M | 169.70M | 100.57M | 36.06M | 14.07M | 4.14M | 35.79K | 35.65K |
| Selling & Marketing | 240.17M | 284.90M | 215.14M | 119.40M | 53.94M | 25.05M | 7.10M | 235.26K |
| SG&A | 386.16M | 454.60M | 315.72M | 155.45M | 68.01M | 29.19M | 35.79K | 35.65K |
| Other Expenses | 424.08M | 119.40M | 48.10M | 12.60M | 8.40M | 1.14M | -32.60 | 41.45K |
| Operating Expenses | 810.24M | 574.00M | 363.81M | 168.05M | 76.40M | 30.32M | 35.76K | 77.10K |
| Cost & Expenses | 1.35B | 1.13B | 736.07M | 303.17M | -33.06M | 27.58M | 35.76K | 77.10K |
| Interest Income | 6.16M | 78.47M | 34.59M | 20.24M | 9.05M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.57M | 79.80M | 34.79M | 20.24M | 12.82M | 2.18M | 0.00 | 0.00 |
| Depreciation & Amortization | 180.99M | 185.57M | 78.22M | 30.19M | 17.19M | 3.11M | 558.01K | 113.20K |
| EBITDA | -21.98M | 239.75M | 283.59M | 207.87M | 128.54M | 38.25M | 10.47M | -4.00M |
| EBITDA Ratio | -1.95% | 18.45% | 30.02% | 39.86% | 119.64% | 74.91% | -0.18% | -4.55% |
| Operating Income | -221.61M | 109.40M | 196.95M | 218.37M | 285.88M | 75.24M | -35.76K | -77.10K |
| Operating Income Ratio | -19.63% | 8.82% | 20.99% | 41.87% | 113.08% | 73.18% | -0.18% | -47.84% |
| Total Other Income/Expenses | -62.92M | -69.40M | -27.80M | -60.85M | -9.59M | -2.04M | -1.63M | -362.15K |
| Income Before Tax | -284.54M | -43.30M | 163.51M | 157.45M | 272.47M | 71.73M | -36.35K | -7.33K |
| Income Before Tax Ratio | -25.20% | -3.49% | 17.42% | 30.19% | 107.77% | 69.76% | -0.18% | -4.55% |
| Income Tax Expense | 151.36M | 161.80M | 146.06M | 94.45M | 94.44M | 28.76M | 4.72M | 0.00 |
| Net Income | -526.80M | -205.10M | 18.03M | 63.00M | 178.03M | 42.97M | -36.35K | -7.33K |
| Net Income Ratio | -46.65% | -16.54% | 1.92% | 12.08% | 70.42% | 41.79% | -0.18% | -4.55% |
| EPS | -2.28 | -1.10 | 0.13 | 0.55 | 1.62 | 0.42 | 0.00 | 0.00 |
| EPS Diluted | -2.79 | -1.09 | 0.12 | 0.53 | 1.54 | 0.42 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 231.11M | 187.27M | 142.65M | 113.57M | 110.21M | 101.70M | 109.81M | 109.81M |
| Weighted Avg Shares Out (Dil) | 188.97M | 188.00M | 146.76M | 118.33M | 115.32M | 103.20M | 109.81M | 109.81M |
Source: https://incomestatements.info
Category: Stock Reports